-
Événement | 2022.12.07
Colloquium "Epidemics, pandemics: a never-ending story?"
On the occasion of the bicentenary of the birth of Louis Pasteur, the Institut Pasteur is organizing a major conference day, open to everyone, on December 7 from 9 a.m., in the auditorium of the Centre d'information scientifique.Program and registration (in French)The goal of this conference is to analyze the major epidemics that have struck humanity since its origin and to draw lessons to...
-
News | 2022.11.17
Royal Society: looking back at the tribute to Louis Pasteur in London
The Institut Pasteur, the French Academy of Sciences and the Royal Society held a scientific symposium that brought French and British researchers together to celebrate the bicentenary of Louis Pasteur's birth and promote international scientific cooperation.
-
News | 2022.11.10
ERC grants: new funding awarded in October 2022
Since they were launched in 2007, European Research Council (ERC) grants have become a mark of scientific excellence. Three new ERC Synergy Grants have recently been awarded for international projects involving scientists working on the Institut Pasteur campus.
-
News | 2022.11.23
"Pasteur": a new biography by Michel Morange
Former researcher at the Pasteur Institute, Michel Morange has published an exclusive biography of Louis Pasteur by Editions Gallimard. The book is available since October 6, 2022.
-
News | 2022.11.22
Mystery of the Cape Verde Zika outbreak solved
Although Zika virus has been responsible for several outbreaks across the planet over the past decade, African countries have remained relatively exempt. But Cape Verde is a notable exception, having experienced a large outbreak in 2015-2016. How can this be explained? Scientists shed light on this seeming paradox.
-
News | 2022.12.07
SpikImm receives a major funding to accelerate the clinical and industrial development of its monoclonal antibodies against SARS-CoV-2
SpikImm, a biotech company founded in 2021 by Truffle Capital in collaboration with the Institut Pasteur, has been awarded a €15 million non-dilutive financing from the French governmentFrance 2030 program for its "PROPHYMAB" project, which is supported as part of the "Emerging Infectious Diseases and CBRN Threats" Acceleration Strategy. SPK001, the first treatment candidate (...
-
Document de presse | 2022.10.20
How SARS-CoV-2 communicates with human cells: mapping molecular contacts
Although the mechanisms by which SARS-CoV-2 enters host cells are increasingly well documented, the direct molecular interactions between virus and host remain poorly understood. Scientists from the Institut Pasteur, the French National Center for Scientific Research (CNRS), Université Paris Cité, the Institute of Network Biology (INET) Helmholtz Munich, the Donnelly Center for Cellular and...
-
News | 2022.12.05
Monnaie de Paris launches a Louis Pasteur commemorative coin
The Monnaie de Paris (Paris Mint) is celebrating the bicentenary of Louis Pasteur's birth by releasing a commemorative coin for sale bearing the scientist's image. For each coin sold, the Monnaie de Paris will donate €1 to the Institut Pasteur's research.
-
News | 2022.12.01
Institut Pasteur at the 2022 Utopiales international science fiction festival in Nantes
For the second year in a row, the Institut Pasteur was one of the official scientific partners of the Utopiales festival, which took place from October 29 to November 1 at La Cité Nantes Congress Center.
-
Portrait | 2022.12.13
Pierre-Marie Lledo: a neuro-optimist in work and in life
Perception, emotions, behavior, decision-making, memory, good mental health, depression – these are some of the research topics that interest Pierre-Marie Lledo. With his team of biologists, physicians, mathematicians, biophysicists and biochemists, he is working to uncover some of the most intimate mechanisms in the brain.
